Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
10 07 2019
Historique:
received: 27 03 2019
accepted: 28 06 2019
entrez: 11 7 2019
pubmed: 11 7 2019
medline: 23 2 2020
Statut: epublish

Résumé

Congenital hypogonadotropic hypogonadism (CHH) is a condition characterized by absent puberty and infertility due to gonadotropin releasing hormone (GnRH) deficiency, which is often associated with anosmia (Kallmann syndrome, KS). We identified loss-of-function heterozygous mutations in anti-Müllerian hormone (

Identifiants

pubmed: 31291191
doi: 10.7554/eLife.47198
pii: 47198
pmc: PMC6620045
doi:
pii:

Substances chimiques

Amhr2 protein, mouse 0
Receptors, Transforming Growth Factor beta 0
Gonadotropin-Releasing Hormone 33515-09-2
Anti-Mullerian Hormone 80497-65-0
Luteinizing Hormone 9002-67-9
Bone Morphogenetic Protein Receptors, Type I EC 2.7.11.30

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-14-CE12-0015-01
Pays : International
Organisme : Horizon 2020 Framework Programme
ID : ERC-2016-CoG 725149
Pays : International
Organisme : Ministerio de Ciencia e Innovación
ID : CTQ2017-87889-P
Pays : International
Organisme : Ministerio de Ciencia e Innovación
ID : CTQ2017-83745-P
Pays : International
Organisme : Horizon 2020 Framework Programme
ID : H2020-MSCA-IF-2017
Pays : International
Organisme : Generalitat de Catalunya
ID : 2017SGR1323
Pays : International

Informations de copyright

© 2019, Malone et al.

Déclaration de conflit d'intérêts

SM, GP, AM, NM, ST, MI, CA, IC, JA, DC, CX, RQ, GS, PP, LA, LM, JM, VP, NP, PG No competing interests declared

Références

Proc Natl Acad Sci U S A. 1989 Oct;86(20):8132-6
pubmed: 2682637
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Cell Metab. 2014 Feb 4;19(2):293-301
pubmed: 24506870
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3334-E3343
pubmed: 28320971
J Clin Invest. 2010 Oct;120(10):3668-72
pubmed: 20940512
Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16421-5
pubmed: 16260730
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7203-8
pubmed: 19359476
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Hum Mutat. 2013 Sep;34(9):E2393-402
pubmed: 23843252
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
J Clin Endocrinol Metab. 2012 Jan;97(1):E136-44
pubmed: 22072740
Mol Endocrinol. 2004 Mar;18(3):708-21
pubmed: 14673134
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Endocr Rev. 2010 Aug;31(4):544-77
pubmed: 20237240
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nat Commun. 2016 Jan 12;7:10055
pubmed: 26753790
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
J Neurosci. 2004 May 19;24(20):4737-48
pubmed: 15152034
Am J Med Genet. 1999 Dec 29;89(4):218-23
pubmed: 10727997
J Neurosci. 1995 Dec;15(12):7769-77
pubmed: 8613718
Cell. 1994 Nov 4;79(3):415-25
pubmed: 7954809
J Clin Endocrinol Metab. 2002 Sep;87(9):4128-36
pubmed: 12213860
Hum Mutat. 2000;15(1):7-12
pubmed: 10612815
Genes Dev. 1996 Oct 15;10(20):2577-87
pubmed: 8895659
Comput Sci Eng. 2015 Jul 1;12(4):34-39
pubmed: 26146490
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Nat Med. 2018 Jun;24(6):834-846
pubmed: 29760445
Endocrinology. 2001 Nov;142(11):4891-9
pubmed: 11606457
Development. 2016 Nov 1;143(21):3969-3981
pubmed: 27803058
Trends Endocrinol Metab. 2003 Mar;14(2):91-7
pubmed: 12591180
Nat Neurosci. 2016 Jun;19(6):835-44
pubmed: 27135215
Hum Reprod Update. 2005 Jul-Aug;11(4):351-6
pubmed: 15878900
Hum Mutat. 2011 Aug;32(8):894-9
pubmed: 21520341
Biol Reprod. 2008 Jun;78(6):994-1001
pubmed: 18322278
J Clin Invest. 2007 Feb;117(2):457-63
pubmed: 17235395
Neuron. 1990 Jul;5(1):1-10
pubmed: 2196069
Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1241-7
pubmed: 24045871
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15140-4
pubmed: 20696889
Nat Genet. 2002 Nov;32(3):408-10
pubmed: 12368913
Hum Mol Genet. 2011 Dec 15;20(24):4759-74
pubmed: 21903667
Mol Hum Reprod. 2015 Jul;21(7):571-82
pubmed: 25920489
Cell Rep. 2014 Nov 20;9(4):1191-201
pubmed: 25456121
Sex Dev. 2017;11(3):109-125
pubmed: 28528332
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Mol Endocrinol. 1994 Aug;8(8):1006-20
pubmed: 7997230
Sci Rep. 2016 Mar 31;6:23790
pubmed: 27030385
Endocrinology. 1999 Dec;140(12):5789-96
pubmed: 10579345
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3402-6
pubmed: 2014260
Nat Genet. 1995 Dec;11(4):382-8
pubmed: 7493017
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Hum Mol Genet. 2009 Aug 15;18(16):3002-13
pubmed: 19457927
Neuroendocrinology. 2019;108(2):65-83
pubmed: 30368511
Biol Open. 2017 Oct 15;6(10):1552-1568
pubmed: 28970231
Nat Rev Endocrinol. 2015 Sep;11(9):547-64
pubmed: 26194704
PLoS One. 2012;7(7):e39001
pubmed: 22802933
Endocrinology. 2013 Dec;154(12):4939-45
pubmed: 24092638
Protein Sci. 1993 Sep;2(9):1511-9
pubmed: 8401235
Endocrinology. 1984 Apr;114(4):1315-20
pubmed: 6546716
J Neurosci. 2007 Jan 10;27(2):431-45
pubmed: 17215404
Cell. 2014 Nov 6;159(4):896-910
pubmed: 25417164
PLoS Genet. 2012 Aug;8(8):e1002896
pubmed: 22927827
J Neurosci. 1999 Mar 15;19(6):2037-50
pubmed: 10066257
J Cell Sci. 2008 Oct 15;121(Pt 20):3357-65
pubmed: 18796535
Dev Biol. 1994 Nov;166(1):331-48
pubmed: 7958456
Nature. 1989 Mar 9;338(6211):161-4
pubmed: 2645530
J Comp Neurol. 1996 Mar 11;366(3):547-57
pubmed: 8907364
Development. 1994 Jan;120(1):189-97
pubmed: 8119126
Mol Cell Endocrinol. 1998 Oct 25;145(1-2):3-7
pubmed: 9922092
J Neurosci. 1988 Feb;8(2):555-63
pubmed: 3276833

Auteurs

Samuel Andrew Malone (SA)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
University of Lille, FHU 1, 000 Days for Health, Lille, France.

Georgios E Papadakis (GE)

Faculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.

Andrea Messina (A)

Faculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.

Nour El Houda Mimouni (NEH)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
University of Lille, FHU 1, 000 Days for Health, Lille, France.

Sara Trova (S)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
University of Lille, FHU 1, 000 Days for Health, Lille, France.

Monica Imbernon (M)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
University of Lille, FHU 1, 000 Days for Health, Lille, France.

Cecile Allet (C)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
University of Lille, FHU 1, 000 Days for Health, Lille, France.

Irene Cimino (I)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.

James Acierno (J)

Faculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.

Daniele Cassatella (D)

Faculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.

Cheng Xu (C)

Faculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.

Richard Quinton (R)

Institute of Genetic Medicine, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, United Kingdom.

Gabor Szinnai (G)

Pediatric Endocrinology and Diabetology, University of Basel Children's Hospital, Basel, Switzerland.

Pascal Pigny (P)

CHU Lille, Laboratoire de Biochimie et Hormonologie, Centre de Biologie Pathologie, Lille, France.

Lur Alonso-Cotchico (L)

Departament de Química, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Laura Masgrau (L)

Departament de Química, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Jean-Didier Maréchal (JD)

Departament de Química, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Vincent Prevot (V)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
University of Lille, FHU 1, 000 Days for Health, Lille, France.

Nelly Pitteloud (N)

Faculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.

Paolo Giacobini (P)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
University of Lille, FHU 1, 000 Days for Health, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH